Padilla-Rosas M, Mendoza-López AL, Romero-Becerra A, Robles-Gómez C, Nava-Villalba M, Puebla-Mora AG, Godinez-Rubí JM, Zepeda-Nuño JS

Language: English
References: 9
Page: 1664-1666
PDF size: 268.30 Kb.

ABSTRACT

Chronic kidney disease is the progressive and irreversible decrease of the glomerular filtration. Because of this, the onset of hormonal and metabolic changes is determined. Among the changes, there are vitamin D, calcium, phosphorus, parathyroid hormone and the acid-base balance. This generates multiple stimuli in the parathyroid gland and develops secondary hyperparathyroidism. Brown tumor represents one of the most common complications of this issue. Hereby, a bibliographic review is made, which encompasses the connections between chronic kidney disease and hyperparathyroidism, since the clinical case of a female patient, with 35 years old, came up. The female presents a record of CKD and a rise in the bilateral intraoral volume in the anterior lower-left area and upper right premolars, without any symptoms, in a slightly violaceous color with telangiectasias on the surface, soft at palpation, with a sessile base, 3 months of evolution and a slow growth. When the patient was directly interviewed, she reported weight loss, general malaise, fatigue, a change in skin color and excessive transpiration. A differential diagnosis is made and it establishes a definite histological diagnosis for the brown tumor of the secondary hyperparothyroidism.

REFERENCES

1. Spuniak MI. Changes in the Mandibular in hyperparathyroid osteodystrophy. Stomatologia 1984; 63(3): 50-51.

2. Mitwalli AH. Spectrum of renal osteodystrophy in dialysis patients at a tertiary hospital, Riyad, Saudi Arabia. Saudi J Kidney Dis Transpl 1998; 9(2): 128-33.

3. Corbetta S, Rossi D, D’Orto O, Vicentini L, Beck-Peccoz P, Spada A. Brown jaw tumors: today’s unusual of primary hyperparathyroidism. J Endocrinol Invest; 26(7): 675-78.

4. Daniels JS. Primary hyperparathyroidism presenting as a palatal brown tumor. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 98(4): 409-13.

5. Carling T, Udelsman R. Parathyroid surgery in familial hyperparatyroid disorders. J Intern Med 2005; 257(1): 27-37.

6. Ferraresi M, Pia A, Guzzo G, Vigotti FN, Mongilardi E, Nazha M, Aroasio E, Gonella C, Avagnina P, Piccoli GB. Calciumphosphate and parathyroid intradialytic profiles: A potential aid for tailoring the dialysate calcium content of patient on different hemodialysis schedules. Hemodial Int 2015; 19(4): 572-82.

7. Dulfer RR, Franssen GJH, Hesselink DA, Hoorn EJ, van Eijck CHJ, van Ginhoven TM. Systematic reviw of surgical and medical treatment for tertiary hyperparathyroidism. Br J Surg 2017; 104(7): 804-13.

8. Jeloka T, Mali M, Jhamnani A, Konde S, Jadhav V. Are we overconcerned about secondary hyperparathyroidism and underestimating the more common secondary hypoparathyroidism in our dialysis patients?. J Assoc Physicians India 2012; 60: 102-05.

9. Spasovski G, Masin-Spasovska J, Gjurchinov D. Succesful treatment of severe secondary hyperparathyroidism (Brown tumor) by kidney transplantation and pulses of oral calcitriol. Clin Transplant 2009; 23(3): 426-30.